291 related articles for article (PubMed ID: 22035630)
1. Platelet dysfunction in vascular pathologies and how can it be treated.
Alexandru N; Popov D; Georgescu A
Thromb Res; 2012 Feb; 129(2):116-26. PubMed ID: 22035630
[TBL] [Abstract][Full Text] [Related]
2. Modulators of platelet function in aging.
Iyer KS; Dayal S
Platelets; 2020 May; 31(4):474-482. PubMed ID: 31524038
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
4. [Platelet inhibition and activation. Mechanisms and clinical implications].
Alberio L; Clemetson KJ
Herz; 2005 May; 30(3):176-80. PubMed ID: 15902367
[TBL] [Abstract][Full Text] [Related]
5. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.
Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H
Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765
[TBL] [Abstract][Full Text] [Related]
6. Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.
Nagy B; Miszti-Blasius K; Kerenyi A; Clemetson KJ; Kappelmayer J
Curr Med Chem; 2012; 19(4):518-31. PubMed ID: 22204330
[TBL] [Abstract][Full Text] [Related]
7. Platelets in vascular disease.
Reinhart WH
Clin Hemorheol Microcirc; 2013; 53(1-2):71-9. PubMed ID: 22954635
[TBL] [Abstract][Full Text] [Related]
8. Platelets as therapeutic targets to prevent atherosclerosis.
Nording H; Baron L; Langer HF
Atherosclerosis; 2020 Aug; 307():97-108. PubMed ID: 32653088
[TBL] [Abstract][Full Text] [Related]
9. Platelets in rheumatic diseases: friend or foe?
Gasparyan AY; Ayvazyan L; Pretorius E; Kitas GD
Curr Pharm Des; 2014; 20(4):552-66. PubMed ID: 23565634
[TBL] [Abstract][Full Text] [Related]
10. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
Khodadi E
Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
[TBL] [Abstract][Full Text] [Related]
11. Platelets as cellular effectors of inflammation in vascular diseases.
Rondina MT; Weyrich AS; Zimmerman GA
Circ Res; 2013 May; 112(11):1506-19. PubMed ID: 23704217
[TBL] [Abstract][Full Text] [Related]
12. Our expanding view of platelet functions and its clinical implications.
Ombrello C; Block RC; Morrell CN
J Cardiovasc Transl Res; 2010 Oct; 3(5):538-46. PubMed ID: 20661787
[TBL] [Abstract][Full Text] [Related]
13. Role of platelets in the pathophysiology of acute coronary syndrome.
Massberg S; Schulz C; Gawaz M
Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
[TBL] [Abstract][Full Text] [Related]
14. Complement links platelets to innate immunity.
Nording H; Langer HF
Semin Immunol; 2018 Jun; 37():43-52. PubMed ID: 29426568
[TBL] [Abstract][Full Text] [Related]
15. The role of platelets in athero-thrombotic events.
Freynhofer MK; Bruno V; Wojta J; Huber K
Curr Pharm Des; 2012; 18(33):5197-214. PubMed ID: 22724408
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis.
Schäfer A; Bauersachs J
Curr Vasc Pharmacol; 2008 Jan; 6(1):52-60. PubMed ID: 18220940
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation in essential hypertension: implications for antiplatelet treatment.
Gkaliagkousi E; Passacquale G; Douma S; Zamboulis C; Ferro A
Am J Hypertens; 2010 Mar; 23(3):229-36. PubMed ID: 20094035
[TBL] [Abstract][Full Text] [Related]
18. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
Gurbel PA
Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet therapy and vascular disease: an update.
Buch MH; Prendergast BD; Storey RF
Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):249-75. PubMed ID: 21303843
[TBL] [Abstract][Full Text] [Related]
20. Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms.
Marin Oyarzún CP; Heller PG
Front Immunol; 2019; 10():1373. PubMed ID: 31258539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
